Allergies
34
7
7
20
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.9%
1 terminated out of 34 trials
95.2%
+8.7% vs benchmark
9%
3 trials in Phase 3/4
20%
4 of 20 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 20 completed trials
Clinical Trials (34)
Improved Child Nutrition and Development Through Social Transfers
Elemental 028 Extra Case Studies
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
Effects of the Mediterranean Diet During Pregnancy on the Onset of Allergies in the Offspring
Omalizumab Weight-Based Dosing Efficacy Trial
Partners in Children's Health (CSN): A Randomized Trial of an Attachment Based Intervention
Healthspan Connect Programme of Research
Evaluation of the Efficacy of Oral Immunotherapy with Raw Apple in Patients Allergic to Birch Pollen and Apple: Prospective, Multicenter, Comparative Phase III Study
Novel Blood Test to Predict Safe Foods for Infants and Toddlers With Food Protein-induced Enterocolitis Syndrome (FPIES)
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
Children's Respiratory and Environmental Workgroup
Benchtop NMR Spectroscopy for Assessment of Clinical Human Pathologies (BRANCH-P STUDY)
The Alberta BLOOM Long Term Follow Up Study
Multi-center, Pediatric, Open-label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec 5.0 mg Chewable Tablet Medications (Study P04574)(COMPLETED)
Multi-Center, Pediatric, Open-Label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec ® 5.0 mg Chewable Tablet Medications (Study P04573) (Completed)
Understanding and Diagnosing Allergic Disease in Twins
Upstate New York Infant Development Screening Program
Children With Asthma in New Orleans After Hurricane Katrina
The Phthalate-Allergen Immune Response Study
Effects of Co-Exposure to Air Pollution and Allergen